Searches for tirzepatide in units ask one of two things: how many syringe units a stated milligram amount is, or how many milligrams a stated unit count holds. Both have the same answer, and it is a sentence rather than a number: it depends on the concentration of the vial. This page sets out the formula once, then gives both tables at every concentration found on dated label and pharmacy pages (read 2026-10-06). It reports arithmetic; it recommends no amount.
The label's dose steps, the per-vial table for research-market vials and the trial record are on the tirzepatide dosage page. The general method for any compound, including the milligram-microgram slips that cause tenfold errors, is on mg to units. The compound itself is covered in Medibact's Tirzepatide guide.
The formula
A U-100 insulin syringe holds 100 units per millilitre, so one unit is 0.01 mL. The insulin syringe units page sets out the scale and the three barrel sizes. The conversion is:
units = amount (mg) ÷ concentration (mg/mL) × 100
and in reverse, mg = units ÷ 100 × concentration (mg/mL). Nothing about tirzepatide changes this; the drug only supplies the amounts that get searched.
Milligrams to units
Each row is one of the label's escalation steps (2.5 mg, then 2.5 mg increments to a 15 mg maximum, per the Zepbound and Mounjaro labels read 2026-10-06). The columns are the concentrations on the two pharmacy chart pages read the same day.
| Amount | 5 mg/mL | 10 mg/mL | 15 mg/mL | 17 mg/mL | 20 mg/mL |
|---|---|---|---|---|---|
| 2.5 mg | 50 units | 25 units | 16.7 units | 14.7 units | 12.5 units |
| 5 mg | 100 units | 50 units | 33.3 units | 29.4 units | 25 units |
| 7.5 mg | 150 units | 75 units | 50 units | 44.1 units | 37.5 units |
| 10 mg | 200 units | 100 units | 66.7 units | 58.8 units | 50 units |
| 12.5 mg | 250 units | 125 units | 83.3 units | 73.5 units | 62.5 units |
| 15 mg | 300 units | 150 units | 100 units | 88.2 units | 75 units |
Read as single sentences: at 5 mg/mL, 2.5 mg = 0.5 mL = 50 units. At 10 mg/mL, 2.5 mg = 0.25 mL = 25 units, and 5 mg = 50 units. At 15 mg/mL, 7.5 mg = 0.5 mL = 50 units. At 20 mg/mL, 10 mg = 0.5 mL = 50 units, and 15 mg = 75 units.
Two things the table shows that the single-number answers do not. First, at 5 mg/mL every step above 5 mg exceeds a 1 mL syringe (100 units); the 15 mg step would be 3 mL. One of the chart pages read for this page says doses above 100 units "require a larger syringe or multiple draws"; that is the arithmetic consequence of a dilute vial, not a property of the drug. Second, the more concentrated the vial, the smaller the volume, and the larger the share of the amount carried by each unit mark. At 20 mg/mL one unit holds 0.2 mg.
Units to milligrams
The reverse lookups are the rising share of searches ("how many mg is 20 units", "40 units", "50 units"). The same five concentrations:
| Units (mL) | 5 mg/mL | 10 mg/mL | 15 mg/mL | 17 mg/mL | 20 mg/mL |
|---|---|---|---|---|---|
| 10 (0.10 mL) | 0.5 mg | 1 mg | 1.5 mg | 1.7 mg | 2 mg |
| 12.5 (0.125 mL) | 0.63 mg | 1.25 mg | 1.88 mg | 2.13 mg | 2.5 mg |
| 15 (0.15 mL) | 0.75 mg | 1.5 mg | 2.25 mg | 2.55 mg | 3 mg |
| 20 (0.20 mL) | 1 mg | 2 mg | 3 mg | 3.4 mg | 4 mg |
| 25 (0.25 mL) | 1.25 mg | 2.5 mg | 3.75 mg | 4.25 mg | 5 mg |
| 30 (0.30 mL) | 1.5 mg | 3 mg | 4.5 mg | 5.1 mg | 6 mg |
| 40 (0.40 mL) | 2 mg | 4 mg | 6 mg | 6.8 mg | 8 mg |
| 50 (0.50 mL) | 2.5 mg | 5 mg | 7.5 mg | 8.5 mg | 10 mg |
| 60 (0.60 mL) | 3 mg | 6 mg | 9 mg | 10.2 mg | 12 mg |
| 75 (0.75 mL) | 3.75 mg | 7.5 mg | 11.25 mg | 12.75 mg | 15 mg |
Every row spans a fourfold range. That spread is the whole answer to "is 20 (or 25, or 50) units a lot": as a measurement it is a volume, and its milligram content is set by a label the syringe never sees. The US labels list 2.5 mg once weekly as the starting amount and 15 mg once weekly as the maximum; whether a given amount suits a given person is not something a chart can say.
Why the labelled products have no unit count
The Zepbound and Mounjaro labels (DailyMed versions published 2026-09-02, read 2026-10-06) list four presentations. The single-dose pen and the single-dose vial hold each strength in 0.5 mL, so their concentrations run 5, 10, 15, 20, 25 and 30 mg/mL. The multi-dose vial and the KwikPen deliver four doses of 0.6 mL each from 2.4 mL, at 4.17 to 25 mg/mL. Put on a U-100 scale, every single-dose amount is 50 units and every multi-dose amount is 60 units, whatever the strength. The pen delivers the whole dose; the vial instructions describe drawing the full 0.5 mL or 0.6 mL with a syringe able to measure it. Units only enter the picture when an amount other than a whole labelled dose is drawn, which is why unit charts come almost entirely from compounded and research-vial use. Lilly's KwikPen and its click charts are covered on Mounjaro pen clicks.
What FDA reports about compounded doses, and how the label's vial rules compare with a compounded vial's, is on compounded tirzepatide compared with Zepbound. A coincidence worth stating: four of the five pharmacy concentrations (5, 10, 15 and 20 mg/mL) are also the concentrations of the 2.5, 5, 7.5 and 10 mg single-dose vials. A unit count from one of those vials therefore matches a compounded vial of the same strength, and no other. Semaglutide's pens follow the same fixed-volume pattern at much lower concentrations, worked through on semaglutide in units.
Rounding
At 5, 10 and 20 mg/mL the label steps land on whole or half units. At 15 and 17 mg/mL they do not, and pharmacy charts round them. At 15 mg/mL, 2.5 mg is 16.67 units; rounded to 17 it is 2.55 mg, 2% over. At 17 mg/mL, 2.5 mg is 14.71 units; rounded to 15 it is also 2.55 mg. Across all twelve rounded cells the largest change is 2%. The larger reading error is the barrel: the 1 mL syringe in BD's FDA clearance (K190054) is marked in 2-unit steps, so an odd-numbered target falls between marks, while the 0.3 mL barrel is marked in 1- or half-unit steps.
What this page does not establish
No label, trial or regulator publishes a tirzepatide amount in syringe units; every unit figure here is arithmetic on a stated concentration. A vial's concentration is only as good as its label, and no source read for this page measured how closely compounded or research vials match theirs. For a research-market powder vial the concentration is whatever the added water makes it; the reconstitution page for tirzepatide and the tirzepatide calculator do that arithmetic for any vial size and volume. Additives in some compounded vials do not change the arithmetic but do change what is in the syringe; they are covered on compounded GLP-1 additives. Nothing here is a suggested amount; decisions about amounts belong with a prescriber.
Sources and dates
Opened 2026-10-06: the ZEPBOUND label (set id 487cd7e7-434c-4925-99fa-aa80b1cc776b, revised 08/2026) and the MOUNJARO label (set id d2d7da5d-ad07-4228-955f-cf7e355c8cc0, revised August 2026) via the DailyMed web services, sections 2 and 3; the compounded tirzepatide charts on transformationhealth.com (dated 2026-04-21) and formblends.com (updated 2026-10-04). Syringe barrel markings from BD's 510(k) K190054, as recorded on this site's insulin syringe page (read 2026-09-18). All unit and milligram arithmetic by this site. Corrections go to the contact page.